Alain Chevallier founded Splicos SAS. Presently, he is President at Artedrone SAS. Mr. Chevallier is also on the board of OPALIA Pharma SA, Carbios SA (former Chairman), Compagnie Immobilière et Commerciale SA and Charro Conseils SAS.
Mr. Chevallier previously was Chief Financial Officer at Deinove SA and Chairman for Deinobiotics SAS (a subsidiary of Deinove SA), Chief Financial Officer for Abivax SA, Principal at Bioring SA, Treasurer of Institute of Cardiometabolisme Nutrition, Chairman & Chief Executive Officer at Holding Incubatrice Chimie Verte SA, Financial Director at Sanofi-Aventis France SA, Member-Executive Board at Aventis Pharma SARL, Partner at AEC Partners SAS and Director at Splicos SAS.
He received an MBA from École des Hautes Études Commerciales de Paris.